When U.S. scientists launch their first large-scale clinical trials for COVID-19 vaccines this summer, Antonio Cisneros wants to make sure people like him are included.
“If I am asked to participate, I will,” said Cisneros, a 34-year-old cinematographer in Los Angeles who has signed up for two large vaccine trial registries.
In a summer dominated by COVID-19 and protests against racial injustice, there are growing demands that vaccine trial participants reflect the entire country.
Phase 1 and Phase 2 clinical trials assess the safety and best doses of vaccines in small groups of people.
AdvertisementDel Rio has had marked success recruiting minorities for HIV trials and expects similar results with the COVID-19 vaccine trial.